ExThera Medical
US-based ExThera Medical LLC specializes in commercial physical and biological R&D for medical devices.
Founded
2008US-based ExThera Medical LLC specializes in commercial physical and biological R&D for medical devices.
ExThera Medical LLC is a US-based company specializing in commercial physical and biological research and development for medical devices. The company's core mission is to innovate life-saving medical technologies. Their notable products include the Seraph® 100 Microbind® Affinity Blood Filter, designed to treat bloodstream infections, and the ONCOBind™ Extracorporeal Procedure Program aimed at treating metastatic cancer. ExThera Medical focuses on addressing critical health challenges, including infectious diseases and cancer.
ExThera Medical has achieved significant milestones, including the Investigational Device Exemption (IDE) approval for their ONCOBind™ program. The Seraph® 100 device has been recognized for its potential in combating pandemics and has been featured in military programs. Dr. Stephen A. Chitty IV, a key figure associated with the company, received the Physician Hero Award from the Georgia Hospital Association. These accomplishments underscore ExThera Medical's impact on advancing medical treatments and improving patient outcomes.
Companies similar to ExThera Medical include Aethlon Medical, Path EX, SeaStar Medical and TheraB Medical.
ExThera Medical was founded in 2008.
ExThera Medical's headquarters is located in Martinez, CA, US.
ExThera Medical's most recent funding round was for $6.7M (USD) in September 2021.
As of Sep 10, 2021, ExThera Medical has disclosed funding of $61.3M (USD). Undisclosed round amounts are excluded.
ExThera Medical has 36 employees as of Feb 5, 2024.
TheraB Medical
therabmedical.com
